MiR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer

Oncology Reports

Volumn 33, Issue 2, 2015, Pages 607-614

  Li, Tao ^a   Gao, Feng ^b   Zhang, Xi Peng ^a  

^a TIANJIN UNION MEDICAL CENTER   (China)

^b Hiser Medical Center   (China)

Author keywords

5 fluorouracil; Chemosensitivity; MicroRNAs; miR 203; Thymidylate synthase

Indexed keywords

FLUOROURACIL; MICRORNA; MICRORNA 203; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN203 MICRORNA, HUMAN; TYMS PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CANCER RESISTANCE; CHEMOSENSITIVITY; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HCT116 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LOVO CELL LINE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SW480 CELL LINE; TUMOR VOLUME; TYMS GENE; UPREGULATION; ANIMAL; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENETICS; HT 29 CELL LINE; METABOLISM; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICRORNAS; THYMIDYLATE SYNTHASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84919460718     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3646     Document Type: Article

References (28)

1. Coget J, Borrini F, Susman S and Sabourin JC: Colorectal carcinomas in 2013: the search for powerful prognostic markers is still on the go! Cancer Biomark 14: 145-150, 2014.
2. No authors listed: Effcacy of adjuvant fuorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345: 939-944, 1995.
3. González-Vallinas M, Molina S, Vicente G, et al: Antitumor effect of 5-fuorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol Res 72: 61-68, 2013.
4. Etienne MC, Chazal M, Laurent-Puig P, et al: Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol 20: 2832-2843, 2002.
5. Copur S, Aiba K, Drake JC, Allegra CJ and Chu E: Thymidylate synthase gene amplifcation in human colon cancer cell lines resistant to 5-fuorouracil. Biochem Pharmacol 49: 1419-1426, 1995.
6. Johnston PG, Lenz HJ, Leichman CG, et al: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fuorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
7. Yeh KH, Shun CT, Chen CL, et al: High expression of thymi-dylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fuorouracil-based systemic chemotherapy. Cancer 82: 1626-1631, 1998.
8. Zhang LY, Liu M, Li X and Tang H: miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocel-lular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem 288: 4035-4047, 2013.
9. Bartel DP: MicroRNAs: genomics, bioGenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
11. Fujita Y, Kojima K, Hamada N, et al: Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119, 2008.
12. Hwang JH, Voortman J, Giovannetti E, et al: Identifcation of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 5: e10630, 2010.
13. Bitarte N, Bandres E, Boni V, et al: MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29: 1661-1671, 2011.
14. Karaayvaz M, Zhai H and Ju J: miR-129 promotes apoptosis and enhances chemosensitivity to 5-fuorouracil in colorectal cancer. Cell Death Dis 4: e659, 2013.
15. Gotanda K, Hirota T, Matsumoto N and Ieiri I: MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fuorouracil sensitivity in HeLa cells. BMC Cancer 13: 369, 2013.
16. Djeu JY and Wei S: Clusterin and chemoresistance. Adv Cancer Res 105: 77-92, 2009.
17. Li JA, Chen YX, Zhao JF, Kong FR and Zhang YD: miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett 304: 52-59, 2011.
18. Yin J, Zheng G, Jia X, et al: A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fuorouracil in breast cancer cells. PLoS One 8: e73268, 2013.
19. Viticchie G, Lena AM, Latina A, et al: MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 10: 1121-1131, 2011.
20. Zhou Y, Wan G, Spizzo R, et al: miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol 8: 83-92, 2014.
21. Jordan MA and Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265, 2004.
22. Tian L, Li M, Ge J, et al: MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol 35: 5953-5963, 2014.
23. Lehman NL: Future potential of thymidylate synthase inhibitors in cancer therapy. Expert Opin Investig Drugs 11: 1775-1787, 2002.
24. Houghton JA, Tillman DM and Harwood FG: Ratio of 2'-deoxy-adenosine-5'-triphosphate/thymidine-5'-triphosphate infuences the commitment of human colon carcinoma cells to thymineless death. Clin Cancer Res 1: 723-730, 1995.
25. Popat S, Matakidou A and Houlston RS: Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 22: 529-536, 2004.
26. Lenz HJ, Hayashi K, Salonga D, et al: p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin Cancer Res 4: 1243-1250, 1998.
27. Cho YB, Chung HJ, Lee WY, et al: Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer. Anticancer Res 31: 3843-3849, 2011.
28. Galbiatti AL, Caldas HC, Maniglia J V, Pavarino EC and Goloni-Bertollo EM: Gene expression profle of 5-fuorouracil metabolic enzymes in laryngeal cancer cell line: predictive parameters for response to 5-fluorouracil-based chemotherapy. Biomed Pharmacother 68: 515-519, 2014.